SRPT Q2 2022 Earnings — Sarepta Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SRPTSarepta Therapeutics, Inc.

$2B

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$233M+42.3% YoY

Gross Profit

$196M83.8% margin

Operating Income

-$211M-90.4% margin

Net Income

-$231M-99.1% margin

EPS (Diluted)

$-2.65

QoQ Revenue Growth

+10.7%

Cash Flow

Operating Cash Flow

-$67M

Free Cash Flow

-$76M

Stock-Based Comp.

$103M

Balance Sheet

Total Assets

$3.0B

Total Liabilities

$2.3B

Stockholders' Equity

$726M

Cash & Equivalents

$869M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$233M	$164M	+42.3%
Gross Profit	$196M	$145M	+35.4%
Operating Income	-$211M	-$168M	-26.0%
Net Income	-$231M	-$81M	-184.4%